MRCP Part 1 Pass Rate 2026: Statistics and How to Beat Them

Featured image for MRCP Part 1 Pass Rate 2026: Statistics and How to Beat Them

The headline MRCP Part 1 pass rate — somewhere between 35% and 45% depending on the sitting — is the single most misleading number in UK postgraduate medical education. It tells you that the exam is hard. It tells you nothing about whether you specifically will pass. The aggregate conceals variation so large that two candidates walking into the same exam room can have genuinely different probabilities of success, determined almost entirely by factors within their control.

Understanding the real statistics — disaggregated by candidate group, attempt number, and time since graduation — transforms the pass rate from a source of anxiety into a strategic tool.

The Headline Numbers in Context

MRCPUK publishes performance data openly through the Federation of Royal Colleges of Physicians. The overall pass rate for Part 1 has historically fluctuated between 35% and 45% across sittings. The pass mark is set using statistical equating with Item Response Theory, calibrated against UK graduate performance as the reference group. This means the standard is fixed — what changes between sittings is the specific difficulty of the paper.

In practical terms: approximately half to two-thirds of candidates fail at any given sitting. MRCP Part 1 is, by objective measurement, among the hardest postgraduate written exams in UK medicine — harder than PLAB 1 (65-75% pass rate), harder than MRCGP AKT (typically 70-80%), and comparable to FRCA Primary in difficulty.

But the aggregate masks everything that matters.

UK Graduates vs International Medical Graduates

The most significant division in MRCP Part 1 performance is between UK graduates and international medical graduates. Published MRCPUK data and academic analyses consistently demonstrate a substantial gap.

UK graduates pass at approximately 50-60% on first attempt — with the highest rates (around 57.5% in published PMC studies) achieved by candidates sitting the exam 12-24 months after graduation. These candidates have spent five years absorbing UK clinical culture, studying from UK-authored textbooks, working in UK hospitals during clinical placements, and learning the management pathways that MRCP questions assume as baseline knowledge.

International medical graduates pass at lower rates — typically 25-40% on first attempt depending on country of primary qualification, with significant variation. Candidates from English-speaking countries with UK-aligned curricula perform closer to UK graduate rates. Candidates from non-English-speaking countries or with curricula that diverge significantly from UK practice face wider gaps.

The gap does not reflect intelligence, clinical ability, or dedication. Research published in the British Medical Journal and Clinical Medicine has identified the primary drivers: differential exposure to UK-specific clinical guidelines (NICE, BNF), language and cultural factors in question interpretation, familiarity with the best-of-five SBA format, and access to UK-calibrated preparation resources.

The practical implication is direct. If you are an IMG, your preparation must specifically address UK-guideline alignment. This is not an add-on to your study plan — it is the foundation. Ask iatroX provides instant clinical reference grounded in NICE, CKS, SIGN, and BNF — the exact guidelines MRCP Part 1 questions are built from. Every wrong Q-bank answer verified against the UK guideline closes one more gap between your international training and the exam's expectations.

Pass Rate by Attempt Number

First-attempt candidates pass at the highest rate. Second-attempt candidates pass at a lower rate. Third and subsequent attempts are lower still. This is a consistent finding across all MRCPUK data.

The decline is not because the exam gets harder on retake — the papers are independently standard-set. The decline occurs because the population of repeat candidates is self-selected for the factors that caused initial failure: insufficient preparation, unaddressed knowledge gaps, misalignment with UK guidelines, or examination technique problems. Candidates who meaningfully change their preparation approach between attempts frequently pass on their second try. Candidates who use the same approach and hope for a different outcome frequently do not.

After a failed attempt, the evidence-based approach is diagnostic: identify specifically which topics you underperformed in (MRCPUK provides some topic-level feedback), change your resource combination (add iatroX Q-Bank for adaptive spaced repetition if you were using linear Q-bank practice alone), increase your question volume toward the 4,000-5,000 threshold that correlates with passing, and address UK-guideline alignment specifically if you are an IMG.

Pass Rate by Time Since Graduation

Published research (Pinheiro-Torres et al., Clinical Medicine) demonstrates that pass rates are highest when candidates sit MRCP Part 1 within 12-24 months of graduating. The rate declines progressively with increasing time since graduation — candidates sitting more than 37 months after graduation have substantially lower pass rates, particularly on subsequent attempts.

This reflects knowledge decay. The basic sciences, clinical pharmacology, and statistics tested in Part 1 are studied intensively during medical school and fade rapidly without active reinforcement once clinical work takes priority. A doctor five years out of medical school may be a more experienced clinician but will have forgotten the enzyme pathways, inheritance patterns, and statistical definitions that Part 1 tests.

For doctors with a longer gap since graduation, the preparation strategy must explicitly address this decay. Clinical sciences (genetics, immunology, biochemistry), pharmacology, and statistics/EBM require dedicated revision time — not just clinical question practice. The iatroX Q-Bank adaptive algorithm is particularly valuable here because it automatically identifies the atrophied knowledge areas and targets them from the first session, rather than requiring you to manually decide which topics to revisit.

How to Beat the Statistics

The pass rates describe populations. Your outcome is determined by your preparation. Here is what the data tells us about the preparation that predicts success.

Question volume matters. Published analyses and candidate data consistently show that candidates who complete 4,000-5,000+ Q-bank questions pass at significantly higher rates than those who complete fewer. This is not mindless repetition — it is systematic exposure to the breadth of the curriculum.

UK-guideline alignment matters. For IMGs especially, the gap between international training and UK exam expectations is the primary barrier. Ask iatroX closes this gap in real time — every clinical question answered with the NICE/BNF recommendation rather than an international guideline is one fewer wrong answer on exam day.

Timing matters. Sit the exam within 2 years of graduating if possible. If not, invest specifically in the basic science and pharmacology topics that decay fastest.

Adaptive learning matters. Linear Q-bank practice — working through questions in order from start to finish — leaves gaps. The iatroX Q-Bank adaptive spaced repetition identifies your weaknesses from the first session and ensures that the topics you are worst at receive the most practice time. This is the algorithmic equivalent of what successful candidates do manually: focus on weaknesses, not comfort zones.

Mock exams matter. Benchmark against full timed mocks, not against aggregate pass rates. If you consistently score above 65% on representative MRCP Part 1 mocks, you are well-positioned regardless of the population statistics.

The 35-45% headline pass rate is real. It is also irrelevant to you personally if you prepare systematically. The candidates who pass are not the ones who read the statistics and felt reassured — they are the ones who used the statistics to identify the preparation factors that matter and then executed them.

Start your preparation with iatroX. Adaptive, guideline-grounded, and designed for exactly the challenge MRCP Part 1 presents.

Share this insight